A vaccine to prevent herpes zoster [3] (multiple letters)

New England Journal of Medicine

Volumn 353, Issue 13, 2005, Pages 1414-1415

  Kessler, Kenneth M ^a   Carroll, Ian ^b   Gaeta, Raymond ^b   Mackey, Sean ^b   Oxman, Michael N ^c   Levin, Myron J ^d   Johnson, Gary R ^e   Tsai, Adam Gilden ^f   Gilden, Donald H ^d  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b STANFORD UNIVERSITY MEDICAL CENTER   (United States)

^c VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

^d UNIVERSITY OF COLORADO   (United States)

^e VA Cooperative Studies Program Coordinating Center   (United States)

^f UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VARICELLA ZOSTER VACCINE; CHICKENPOX VACCINE;

COST CONTROL; COST EFFECTIVENESS ANALYSIS; HERPES ZOSTER; HUMAN; LETTER; LIFE EXPECTANCY; POSTHERPETIC NEURALGIA; PRIORITY JOURNAL; QUALITY ADJUSTED LIFE YEAR; SURVIVAL; VACCINATION; AGED; COST BENEFIT ANALYSIS; COST OF ILLNESS; ECONOMICS; NEURALGIA; NOTE; VIROLOGY;

AGED; CHICKENPOX VACCINE; COST OF ILLNESS; COST-BENEFIT ANALYSIS; HERPES ZOSTER; HUMANS; NEURALGIA; QUALITY-ADJUSTED LIFE YEARS;

EID: 25444531661     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJMc051795     Document Type: Letter

References (0)